Shawn Jackson, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| AIDS Vaccines | 7 | 2011 | 938 | 0.720 |
Why?
|
| Analgesia | 1 | 2023 | 461 | 0.670 |
Why?
|
| Critical Illness | 1 | 2023 | 2670 | 0.380 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 370 | 0.320 |
Why?
|
| Adenoviridae | 1 | 2011 | 1099 | 0.300 |
Why?
|
| Interferon-gamma | 4 | 2011 | 3206 | 0.270 |
Why?
|
| L-Selectin | 1 | 2005 | 213 | 0.260 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2011 | 1821 | 0.250 |
Why?
|
| Vaccinia virus | 3 | 2005 | 349 | 0.250 |
Why?
|
| Genetic Vectors | 4 | 2011 | 3420 | 0.240 |
Why?
|
| Vaccines, DNA | 6 | 2005 | 305 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2011 | 4479 | 0.220 |
Why?
|
| Antibodies | 1 | 2011 | 2460 | 0.220 |
Why?
|
| Vaccines, Synthetic | 3 | 2011 | 634 | 0.180 |
Why?
|
| HIV-1 | 5 | 2011 | 6939 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 9 | 2011 | 6386 | 0.170 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 1838 | 0.150 |
Why?
|
| Hypnotics and Sedatives | 1 | 2023 | 1162 | 0.130 |
Why?
|
| Adenoviruses, Human | 2 | 2005 | 257 | 0.110 |
Why?
|
| Respiration, Artificial | 1 | 2023 | 2569 | 0.110 |
Why?
|
| Anesthesiology | 1 | 2022 | 1060 | 0.110 |
Why?
|
| HIV Envelope Protein gp120 | 4 | 2005 | 952 | 0.100 |
Why?
|
| Lymphocyte Activation | 4 | 2005 | 5524 | 0.090 |
Why?
|
| Viral Vaccines | 2 | 2005 | 636 | 0.080 |
Why?
|
| Pain | 1 | 2023 | 4986 | 0.080 |
Why?
|
| Immunologic Memory | 2 | 2005 | 1348 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 2 | 2011 | 1000 | 0.080 |
Why?
|
| Plasmids | 4 | 2004 | 2307 | 0.070 |
Why?
|
| Immunization, Secondary | 2 | 2005 | 340 | 0.070 |
Why?
|
| Lethal Dose 50 | 1 | 2005 | 77 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19905 | 0.070 |
Why?
|
| Genitalia | 1 | 2004 | 112 | 0.060 |
Why?
|
| Immunization | 2 | 2005 | 1256 | 0.060 |
Why?
|
| Adenovirus Infections, Human | 1 | 2004 | 71 | 0.060 |
Why?
|
| Antibodies, Viral | 2 | 2005 | 3176 | 0.060 |
Why?
|
| Colony-Stimulating Factors | 1 | 2003 | 221 | 0.060 |
Why?
|
| Mice | 11 | 2011 | 81183 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2022 | 5788 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 903 | 0.050 |
Why?
|
| Capsid Proteins | 1 | 2005 | 479 | 0.050 |
Why?
|
| Infant | 1 | 2023 | 35136 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 579 | 0.050 |
Why?
|
| Virulence | 1 | 2005 | 1333 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1880 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2004 | 973 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2004 | 4386 | 0.050 |
Why?
|
| Spleen | 1 | 2005 | 2362 | 0.040 |
Why?
|
| Chemokines | 1 | 2003 | 970 | 0.040 |
Why?
|
| HIV Infections | 1 | 2005 | 16718 | 0.040 |
Why?
|
| Child | 2 | 2023 | 77709 | 0.040 |
Why?
|
| HIV Antibodies | 1 | 2005 | 1322 | 0.040 |
Why?
|
| Animals | 11 | 2011 | 168757 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2005 | 2751 | 0.040 |
Why?
|
| Colon | 1 | 2004 | 1772 | 0.040 |
Why?
|
| Vaccination | 2 | 2005 | 3278 | 0.030 |
Why?
|
| Chemokine CCL4 | 2 | 2004 | 128 | 0.030 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2004 | 122 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9274 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 1076 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 4420 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2004 | 2725 | 0.030 |
Why?
|
| Neutralization Tests | 2 | 2005 | 758 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 2291 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2004 | 2988 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2005 | 10481 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2004 | 4445 | 0.020 |
Why?
|
| Female | 6 | 2011 | 380194 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3870 | 0.020 |
Why?
|
| Chemokine CCL3 | 1 | 2004 | 83 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2005 | 370 | 0.020 |
Why?
|
| Humans | 5 | 2023 | 744343 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2005 | 267 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2004 | 329 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2005 | 401 | 0.010 |
Why?
|
| Serotyping | 1 | 2004 | 338 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2004 | 607 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2004 | 844 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2004 | 675 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 11366 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2002 | 552 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2002 | 442 | 0.010 |
Why?
|
| Epitopes | 1 | 2004 | 2571 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2004 | 2225 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2004 | 1904 | 0.010 |
Why?
|
| Cancer Vaccines | 1 | 2004 | 1023 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2005 | 21827 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2004 | 2585 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 4149 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 18111 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 7322 | 0.010 |
Why?
|
| Cell Movement | 1 | 2002 | 5217 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7880 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 4931 | 0.000 |
Why?
|
| Lung | 1 | 2004 | 9856 | 0.000 |
Why?
|
| Time Factors | 1 | 2004 | 40075 | 0.000 |
Why?
|
| Adult | 1 | 2005 | 214055 | 0.000 |
Why?
|
| Male | 1 | 2004 | 350118 | 0.000 |
Why?
|